Lucas Svetlana — SEC Form 4 filings
SEC reporting owner CIK 1781292. 8 Form 4 filings on record with FilingPulse; latest filed 2026-08-04.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-05-23 to 2026-08-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 23,000 shares, $93,600 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: purchase of 20,000 shares @ $2.43 ($48,600) in Jasper Therapeutics, Inc., filed 2025-09-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | Director | 4 | 1 leg · 20,000 sh · $48,600 | — | 4 |
| Scribe Therapeutics, Inc. (SCTX) | Chief Business Officer | 1 | 1 leg · 3,000 sh · $45,000 | — | 3 |
| aTYR PHARMA INC (ATYR) | Director | 3 | — | — | 3 |
Form 4 filings — Lucas Svetlana
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-04 | 4 | Jasper Therapeutics, Inc. (JSPR) | Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2026-07-27 | 4 | Scribe Therapeutics, Inc. (SCTX) | Purchase (P): 3,000 @ $15 · Grant/award (A): 9,547 (derivative) @ $0 · Grant/award (A): 109,426 (derivative) @ $0 · Grant/award (A): 109,426 (derivative) @ $0 | EDGAR |
| 2026-05-13 | 4 | aTYR PHARMA INC (ATYR) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-09-24 | 4 | Jasper Therapeutics, Inc. (JSPR) | Purchase (P): 20,000 @ $2.43 · Purchase (P): 20,000 (derivative) | EDGAR |
| 2025-07-03 | 4 | Jasper Therapeutics, Inc. (JSPR) | Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2025-05-02 | 4 | aTYR PHARMA INC (ATYR) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | Jasper Therapeutics, Inc. (JSPR) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | aTYR PHARMA INC (LIFE) | Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1781292 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →